• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发生在年轻女性(<35岁)中的乳腺癌有所不同。

Breast carcinomas occurring in young women (< 35 years) are different.

作者信息

Walker R A, Lees E, Webb M B, Dearing S J

机构信息

Breast Cancer Research Unit, University of Leicester, Glenfield Hospital, UK.

出版信息

Br J Cancer. 1996 Dec;74(11):1796-800. doi: 10.1038/bjc.1996.632.

DOI:10.1038/bjc.1996.632
PMID:8956795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2077218/
Abstract

One hundred and sixty-three breast carcinomas occurring in women aged between 26 and 44 years were examined for pathological features, oestrogen and progesterone receptor status, proliferation as determined by Ki-67 labelling and the presence of c-erbB-2 and p53 protein, and were compared with a control group of carcinomas from women in the 50-67 years age group. Carcinomas occurring in women aged under 35 years had a significantly high incidence of being poorly differentiated and of having high proliferation rates. This group also had a significantly high incidence of p53 protein staining. Carcinomas in the under 30 years age group had a lower incidence of oestrogen and progesterone receptor positivity. No differences were found in c-erbB-2-positive staining between the groups. Infiltrating lobular carcinomas were only identified in women aged 40 years and over. There was a higher incidence of a family history in the 35-44 years age group (18%) than in the under 35 years age group (11%). Breast carcinomas occurring in women aged under 35 years are more aggressive. An important finding is the high incidence of p53 positivity, which may indicate genetic instability.

摘要

对163例年龄在26至44岁之间的女性乳腺癌患者进行了病理特征、雌激素和孕激素受体状态、通过Ki-67标记测定的增殖情况以及c-erbB-2和p53蛋白表达情况的检查,并与一组年龄在50至67岁之间的女性乳腺癌对照组进行了比较。35岁以下女性发生的乳腺癌中,低分化和高增殖率的发生率显著较高。该组中p53蛋白染色的发生率也显著较高。30岁以下年龄组的乳腺癌中,雌激素和孕激素受体阳性的发生率较低。两组之间c-erbB-2阳性染色未发现差异。浸润性小叶癌仅在40岁及以上的女性中发现。35至44岁年龄组(18%)的家族史发生率高于35岁以下年龄组(11%)。35岁以下女性发生的乳腺癌侵袭性更强。一个重要发现是p53阳性的高发生率,这可能表明基因不稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1871/2077218/7dd673ca11e5/brjcancer00027-0110-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1871/2077218/7dd673ca11e5/brjcancer00027-0110-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1871/2077218/7dd673ca11e5/brjcancer00027-0110-a.jpg

相似文献

1
Breast carcinomas occurring in young women (< 35 years) are different.发生在年轻女性(<35岁)中的乳腺癌有所不同。
Br J Cancer. 1996 Dec;74(11):1796-800. doi: 10.1038/bjc.1996.632.
2
Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.乳腺癌印迹物中线粒体 UCP4 和 bcl-2 的表达:与 DNA 倍性和经典预后因素的关系。
Pathol Res Pract. 2011 Jun 15;207(6):377-82. doi: 10.1016/j.prp.2011.03.007. Epub 2011 May 31.
3
Expression of c-erbB3 protein in primary breast carcinomas.c-erbB3蛋白在原发性乳腺癌中的表达
Br J Cancer. 1998 Nov;78(10):1385-90. doi: 10.1038/bjc.1998.689.
4
p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?三阴性高级别乳腺癌患者形态学正常/良性乳腺组织中的p53改变:乳腺p53特征?
Hum Pathol. 2016 Sep;55:196-201. doi: 10.1016/j.humpath.2016.05.011. Epub 2016 May 28.
5
The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.表皮生长因子受体(EGFR)、C-erbB-2、Ki-67和增殖细胞核抗原(PCNA)表达在乳腺癌中的预后意义
Anticancer Res. 1996 Sep-Oct;16(5B):3141-7.
6
HER2 as a prognostic factor in breast cancer.HER2作为乳腺癌的一个预后因素。
Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404.
7
Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.乳腺浸润性导管癌:激素、HER-2受体及Ki-67增殖标志物分析
Coll Antropol. 2008 Sep;32(3):741-6.
8
Breast carcinoma in women 35 years and younger: a pathological study.35岁及以下女性乳腺癌:一项病理学研究。
Pathology. 2006 Jun;38(3):219-22. doi: 10.1080/00313020600699268.
9
Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.P-钙黏蛋白的表达与乳腺癌的病理及功能分化相关,而E-钙黏蛋白或N-钙黏蛋白则不然。
Mol Pathol. 2003 Dec;56(6):318-22. doi: 10.1136/mp.56.6.318.
10
Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.通过多参数流式细胞术检测人乳腺癌中p53、Her-2/neu和ras过表达与非整倍体之间的相关性:浸润性导管癌中共同表型进化模式的证据
Clin Cancer Res. 2000 Jan;6(1):112-26.

引用本文的文献

1
Clinicopathological characteristics and prognostic outcomes of young adult women (aged 18-30 years) with breast cancer in Ahmedabad, India: a single-centre, retrospective observational study.印度艾哈迈达巴德市18至30岁年轻成年女性乳腺癌的临床病理特征及预后结果:一项单中心回顾性观察研究
Lancet Reg Health Southeast Asia. 2025 Jul 28;40:100643. doi: 10.1016/j.lansea.2025.100643. eCollection 2025 Sep.
2
Clinicopathological prognostic factors for survival in patients with breast cancer: a retrospective study from a tertiary cancer centre from North-West India.乳腺癌患者生存的临床病理预后因素:来自印度西北部一家三级癌症中心的回顾性研究。
Ecancermedicalscience. 2025 Mar 6;19:1865. doi: 10.3332/ecancer.2025.1865. eCollection 2025.
3

本文引用的文献

1
Younger women with breast carcinoma have a poorer prognosis than older women.患有乳腺癌的年轻女性比年长女性的预后更差。
Cancer. 1996 Jan 1;77(1):97-103. doi: 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3.
2
Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.Ki-67免疫标记在原发性可手术乳腺癌中的预后价值
Br J Cancer. 1993 Sep;68(3):579-83. doi: 10.1038/bjc.1993.389.
3
p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.
Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay Results.基于下一代测序的多基因检测在根据21基因检测结果治疗的早期乳腺癌患者中的预后性能
Cancer Res Treat. 2025 Jul;57(3):749-759. doi: 10.4143/crt.2024.1035. Epub 2024 Dec 23.
4
Patterns of Care, Prognostic Factors, and Survival Outcomes for Patients of Cervical Carcinoma: A Study From North India.宫颈癌患者的护理模式、预后因素及生存结果:一项来自印度北部的研究。
Cureus. 2024 Oct 19;16(10):e71824. doi: 10.7759/cureus.71824. eCollection 2024 Oct.
5
Survival probabilities and prognostic factors of pregnancy-associated breast cancer in Malaysian women.马来西亚女性妊娠相关乳腺癌的生存概率及预后因素
Obstet Gynecol Sci. 2024 Jan;67(1):76-85. doi: 10.5468/ogs.23151. Epub 2023 Nov 21.
6
Risk, molecular subtype and prognosis of second primary breast cancer: an analysis based on first primary cancers.第二原发性乳腺癌的风险、分子亚型及预后:基于第一原发性癌症的分析
Am J Cancer Res. 2023 Jul 15;13(7):3203-3220. eCollection 2023.
7
Updates on Lymphovascular Invasion in Breast Cancer.乳腺癌中淋巴管侵犯的最新进展
Biomedicines. 2023 Mar 21;11(3):968. doi: 10.3390/biomedicines11030968.
8
Do prognosis and clinicopathological features differ in young early-stage breast cancer?年轻早期乳腺癌的预后和临床病理特征是否存在差异?
Front Surg. 2022 Oct 19;9:900363. doi: 10.3389/fsurg.2022.900363. eCollection 2022.
9
Breast Carcinoma in Young Females: A Prospective Study in Terms of Clinicopathological Presentation at a Tertiary Care Center in India.年轻女性乳腺癌:印度一家三级医疗中心关于临床病理表现的前瞻性研究
Cureus. 2022 Jul 25;14(7):e27237. doi: 10.7759/cureus.27237. eCollection 2022 Jul.
10
Effect of Intensive Psychological Care on Patients with Benign Breast Lumps after Mammotome-Assisted Tumor Resection.密集心理护理对麦默通辅助肿瘤切除术后乳腺良性肿块患者的影响
Evid Based Complement Alternat Med. 2022 Jun 24;2022:9054266. doi: 10.1155/2022/9054266. eCollection 2022.
乳腺癌中的p53基因突变与类固醇受体状态。临床病理相关性及预后评估。
Cancer. 1994 Apr 15;73(8):2147-56. doi: 10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5.
4
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.WAF1/CIP1在p53介导的G1期阻滞和凋亡过程中被诱导。
Cancer Res. 1994 Mar 1;54(5):1169-74.
5
Age as prognostic factor in premenopausal breast carcinoma.
Lancet. 1993 Apr 24;341(8852):1039-43. doi: 10.1016/0140-6736(93)92407-k.
6
Breast cancer outcome and predictors of outcome: are there age differentials?乳腺癌的预后及预后预测因素:是否存在年龄差异?
J Natl Cancer Inst Monogr. 1994(16):35-42.
7
Pathology and heredity of breast cancer in younger women.年轻女性乳腺癌的病理学与遗传学
J Natl Cancer Inst Monogr. 1994(16):23-34.
8
Pathological and biological features of mammographically detected invasive breast carcinomas.乳腺钼靶检测到的浸润性乳腺癌的病理和生物学特征。
Br J Cancer. 1995 Jan;71(1):150-4. doi: 10.1038/bjc.1995.31.
9
Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?乳腺癌中p53蛋白的免疫组织化学检测:一个重要的新的独立预后指标?
Hum Pathol. 1993 May;24(5):469-76. doi: 10.1016/0046-8177(93)90158-d.
10
Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features.
Int J Cancer. 1995 Jul 17;62(2):138-44. doi: 10.1002/ijc.2910620205.